Significans iter MAPK/ERK (Latin Wikipedia)

Analysis of information sources in references of the Wikipedia article "Significans iter MAPK/ERK" in Latin language version.

refsWebsite

Global rank Latin rank

4^th place

12^th place

4,489^th place

5,791^st place

1aacrjournals.org

8,869^th place

5,792^nd place

aacrjournals.org

clincancerres.aacrjournals.org

Sebolt-Leopold JS (iun 2008). "Advances in the development of cancer therapeutics directed against the RAS-mitogen-activated protein kinase pathway". Clin. Cancer Res. 14 (12): 3651–6 .

karger.com

content.karger.com

Hilger RA, Scheulen ME, Strumberg D (dec 2002). "The Ras-Raf-MEK-ERK pathway in the treatment of cancer" (PDF). Onkologie 25 (6): 511–8 .

nih.gov

ncbi.nlm.nih.gov

Lake D, Corrêa SA, Müller J (2016). "Negative feedback regulation of the ERK1/2 MAPK pathway". Cell Mol Life Sci 73 (23): 4397-413
Oda K, Matsuoka Y, Funahashi A, Kitano H (2005). "A comprehensive pathway map of epidermal growth factor receptor signaling". Mol Syst Biol 1: 2005.0010

pubmed.ncbi.nlm.nih.gov

Stutvoet T. S., Kol A., et al. (Sep 2019). "MAPK Pathway Activity Plays a Key Role in PD-L1 Expression of Lung Adenocarcinoma Cells". The journal of pathology 249 (1): 52-64